NCT02723942 2020-07-16
CAR-T Cell Immunotherapy for HCC Targeting GPC3
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Withdrawn
Fuda Cancer Hospital, Guangzhou
Shenzhen BinDeBio Ltd.
First Affiliated Hospital of Chengdu Medical College
Shanghai GeneChem Co., Ltd.